ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7%
Tue, 27 Nov

ASTRAZENECA PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m1,6431,6141,6140.0%-1.8%
Other incomeRs m253434-2.0%34.4%
TurnoverRs m1,6681,6491,647-0.1%-1.2%
ExpensesRs m1,2861,5221,466-3.7%14.0%
Gross profitRs m3579314859.1%-58.6%
DepreciationRs m3736373.5%-2.0%
InterestRs m0000.0%0.0%
Profit before taxRs m3449214457.8%-58.0%
TaxRs m70285392.5%-24.2%
Profit after taxRs m274649142.8%-66.7%
Gross profit margin%21.75.79.1
Effective tax rate%20.430.136.8
Net profit margin%16.43.95.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 1.8% on a year-on-year (YoY) basis. The expenses were up by 14.0% YoY during the same period.
  • The company's operating profit declined by 58.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 9.1% in 2QFY19 as against 21.7% in 2QFY18.
  • Depreciation charges declined by 2.0% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 34.4% YoY during the quarter.
  • Net profit for the quarter declined by 66.7% YoY. Net profit margins during the quarter declined from 16.4% in 2QFY18 to 5.5% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 0.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 3.7% QoQ during the same period.
  • The company's operating profit increased by 59.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 9.1% in 2QFY19 as against 5.7% in 1QFY18.
  • Net profit for the quarter increased by 42.8% QoQ, while net profit margins increased from 3.9% in 1QFY18 to 5.5% in 2QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 1,144.2 to Rs 1,466.2, registering a Gain of Rs 322.1 or around 28.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,047.4 (down 0.9%). Over the last one year it has moved down from 14,073.9 to 14,047.4, a gain of 27 points (down 0.2%).

Overall, the S&P BSE SENSEX is up 5.2% over the year.

Current Valuations

At the current price of Rs 1,466.2, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 436.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 21.4 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Jan 20, 2020 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - WYETH LTD COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS